Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects
Status:
Recruiting
Trial end date:
2024-10-17
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to evaluate the safety, tolerability, pharmacokinetics and
pharmacodynamics of single and multiple doses and Drug Drug Interaction of MBX 1416 in
healthy volunteers
This study includes 3 parts. Part A involves a single dose of MBX 1416 or placebo taken as a
subcutaneous injection (SC). Part B involves repeat doses of MBX 1416 or placebo taken as a
subcutaneous injection (SC). Part C involves the evaluation of rosuvastatin and acetaminophen
pharmacokinetics in the presence and absence of MBX 1416.